{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:51:59Z","timestamp":1784098319920,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Danida Research Council","award":["09-096LIFE"],"award-info":[{"award-number":["09-096LIFE"]}]},{"name":"DBL-Centre for Health Research and Development, University of Copenhagen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2999-x","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T06:10:19Z","timestamp":1532067019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration"],"prefix":"10.1186","volume":"11","author":[{"given":"Yahya A.","family":"Derua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Kisinza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"2999_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002562","volume":"7","author":"JD Keenan","year":"2013","unstructured":"Keenan JD, Hotez PJ, Amza A, Stoller NE, Gaynor BD, Porco TC, et al. Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts. PLoS Negl Trop Dis. 2013;7:e2562.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev.ento.54.110807.090626","volume":"54","author":"MJ Bockarie","year":"2009","unstructured":"Bockarie MJ, Pedersen EM, White GB, Michael E. Role of vector control in the global program to eliminate lymphatic filariasis. Annu Rev Entomol. 2009;54:469\u201387.","journal-title":"Annu Rev Entomol."},{"key":"2999_CR3","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution. and disease burden. PLoS Negl Trop Dis. 2009;3:e412.","journal-title":"and disease burden. PLoS Negl Trop Dis."},{"key":"2999_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001366","volume":"5","author":"LM Zeldenryk","year":"2011","unstructured":"Zeldenryk LM, Gray M, Speare R, Gordon S, Melrose W. The emerging story of disability associated with lymphatic filariasis: a critical review. PLoS Negl Trop Dis. 2011;5:e1366.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR5","first-page":"10","volume":"4","author":"MN Malecela","year":"2009","unstructured":"Malecela MN, Lazarus W, Mwingira U, Mwakitalu E, Makene C, Kabali C, et al. Eliminating LF: a progress report from Tanzania. J Lymphol. 2009;4:10\u20132.","journal-title":"J Lymphol."},{"key":"2999_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","volume":"5","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA. Editorial: The Global Programme to Eliminate Lymphatic Filariasis. Trop Med Int Heal. 2000;5:591\u20134.","journal-title":"Trop Med Int Heal."},{"issue":"Suppl. 2","key":"2999_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1179\/000349802125002374","volume":"96","author":"D Molyneux","year":"2002","unstructured":"Molyneux D, Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol. 2002;96(Suppl. 2):15\u201340.","journal-title":"Ann Trop Med Parasitol."},{"key":"2999_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","volume":"61","author":"EA Ottesen","year":"2006","unstructured":"Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol. 2006;61:395\u2013441.","journal-title":"Adv Parasitol."},{"key":"2999_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(04)00973-9","volume":"4","author":"E Michael","year":"2004","unstructured":"Michael E, Malecela-Lazaro MN, Simonsen PE, Pedersen EM, Barker G, Kumar A, et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis. 2004;4:223\u201334.","journal-title":"Lancet Infect Dis."},{"key":"2999_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003669","volume":"9","author":"MP Rebollo","year":"2015","unstructured":"Rebollo MP, Mohammed KA, Thomas B, Ame S, Ali SM, Cano J, et al. Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted? PLoS Negl Trop Dis. 2015;9:e0003669.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13071-014-0507-5","volume":"7","author":"PE Simonsen","year":"2014","unstructured":"Simonsen PE, Derua YA, Magesa SM, Pedersen EM, Stensgaard A-S, Malecela MN, et al. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration. Parasit Vectors. 2014;7:507.","journal-title":"Parasit Vectors."},{"key":"2999_CR12","unstructured":"WHO. Global Programme to Eliminate Lymphatic Filariasis: Progress report, 2015. Wkly Epidemiol Rec. 2016;39:441\u201360."},{"key":"2999_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4269\/ajtmh.13-0407","volume":"90","author":"PJ Budge","year":"2014","unstructured":"Budge PJ, Dorkenoo AM, Sodahlon YK, Fasuyi OB, Mathieu E. Ongoing surveillance for lymphatic filariasis in Togo: assessment of alternatives and nationwide reassessment of transmission status. Am J Trop Med Hyg. 2014;90:89\u201395.","journal-title":"Am J Trop Med Hyg."},{"key":"2999_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002080","volume":"7","author":"YK Sodahlon","year":"2013","unstructured":"Sodahlon YK, Dorkenoo AM, Morgah K, Nabiliou K, Agbo K, Miller R, et al. A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation. PLoS Negl Trop Dis. 2013;7:e2080.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR15","doi-asserted-by":"crossref","unstructured":"Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 2006:226\u201333.","DOI":"10.1016\/j.pt.2006.03.005"},{"key":"2999_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/trstmh\/trx007","volume":"110","author":"NK Biritwum","year":"2016","unstructured":"Biritwum NK, Yikpotey P, Marfo BK, Odoom S, Mensah EO, Asiedu O, et al. Persistent \u201chotspots\u201d of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana. Trans R Soc Trop Med Hyg. 2016;110:690\u20135.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"2999_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109316","volume":"9","author":"WJ Kisoka","year":"2014","unstructured":"Kisoka WJ, Simonsen PE, Malecela MN, Tersb\u00f8l BP, Mushi DL, Meyrowitsch DW. Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania. PLoS One. 2014;9:e109316.","journal-title":"PLoS One."},{"key":"2999_CR18","first-page":"517","volume":"45","author":"M Parker","year":"2013","unstructured":"Parker M, Allen T. Will mass drug administration eliminate lymphatic filariasis? Evidence from northern coastal Tanzania. J Biosoc Sci. 2013;45:517\u201345.","journal-title":"Evidence from northern coastal Tanzania. J Biosoc Sci."},{"key":"2999_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU. Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7:e2447.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-016-1311-1","volume":"9","author":"KV Shuford","year":"2016","unstructured":"Shuford KV, Turner HC, Anderson RM. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors. 2016;9:29.","journal-title":"Parasit Vectors."},{"key":"2999_CR21","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1371\/journal.pntd.0000696","volume":"4","author":"PE Simonsen","year":"2010","unstructured":"Simonsen PE, Pedersen EM, Rwegoshora RT, Malecela MN, Derua YA, Magesa SM. Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLoS Negl Trop Dis. 2010;4:e696.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1471-2334-13-335","volume":"13","author":"PE Simonsen","year":"2013","unstructured":"Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM. Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission. BMC Infect Dis. 2013;13:335.","journal-title":"BMC Infect Dis."},{"key":"2999_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.inhe.2011.06.009","volume":"3","author":"PE Simonsen","year":"2011","unstructured":"Simonsen PE, Magesa SM, Derua YA, Rwegoshora RT, Malecela MN, Pedersen EM. Monitoring lymphatic filariasis control in Tanzania: effect of repeated mass drug administration on circulating filarial antigen prevalence in young schoolchildren. Int Health. 2011;3:182\u20137.","journal-title":"Int Health."},{"key":"2999_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/1755-6783.95962","volume":"5","author":"D Njomo","year":"2012","unstructured":"Njomo D, Mukoko D, Njenga S, Amuyunzu-Nyamongo M, Magambo J. Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results. Ann Trop Med Public Heal. 2012;5:103\u201310.","journal-title":"Ann Trop Med Public Heal."},{"key":"2999_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-3305-1-14","volume":"1","author":"MLE Amarillo","year":"2008","unstructured":"Amarillo MLE, Belizario VY, Sadiang-Abay JT, Sison SAM, Dayag AMS. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur. Philippines. Parasit Vectors. 2008;1:14.","journal-title":"Philippines. Parasit Vectors."},{"key":"2999_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.trstmh.2006.09.002","volume":"101","author":"S Gunawardena","year":"2007","unstructured":"Gunawardena S, Ismail M, Bradley M, Karunaweera N. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western Province of Sri Lanka. Trans R Soc Trop Med Hyg. 2007;101:445\u201353.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"Suppl. 1","key":"2999_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.actatropica.2010.08.021","volume":"120","author":"JD King","year":"2011","unstructured":"King JD, Zielinski-Gutierrez E, Pa\u2019au M, Lammie P. Improving community participation to eliminate lymphatic filariasis in American Samoa. Acta Trop. 2011;120(Suppl. 1):48\u201354.","journal-title":"Acta Trop."},{"key":"2999_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","volume":"102","author":"BV Babu","year":"2008","unstructured":"Babu BV, Mishra S. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Trans R Soc Trop Med Hyg. 2008;102:1207\u201313.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"2999_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0001-706X(95)00126-Y","volume":"60","author":"PE Simonsen","year":"1995","unstructured":"Simonsen PE, Meyrowitsch DW, Makunde WH, Magnussen P. Bancroftian filariasis: the pattern of microfilaraemia and clinical manifestations in three endemic communities of northeastern Tanzania. Acta Trop. 1995;60:179\u201387.","journal-title":"Acta Trop."},{"key":"2999_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S0950268800047932","volume":"105","author":"L Brabin","year":"1990","unstructured":"Brabin L. Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunity. Epidemiol Infect. 1990;105:335\u201353.","journal-title":"Epidemiol Infect."},{"key":"2999_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1756-3305-7-300","volume":"7","author":"CB Chesnais","year":"2014","unstructured":"Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, et al. A case study of risk factors for lymphatic filariasis in the Republic of Congo. Parasit Vectors. 2014;7:300.","journal-title":"Parasit Vectors."},{"key":"2999_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ije\/30.2.394","volume":"30","author":"S Dissanayake","year":"2001","unstructured":"Dissanayake S. In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease. Int J Epidemiol. 2001;30:394\u20139.","journal-title":"Int J Epidemiol."},{"key":"2999_CR33","first-page":"63","volume":"37","author":"DE Abaru","year":"1980","unstructured":"Abaru DE, McMahon JE, Marshall TF, Hamilton PJ, Vaughan JP, Wegesa P. Tanzania filariasis project: studies on microfilaraemia and selected clinical manifestations of Bancroftian filariasis. Acta Trop. 1980;37:63\u201371.","journal-title":"Acta Trop."},{"key":"2999_CR34","doi-asserted-by":"publisher","first-page":"e728","DOI":"10.1371\/journal.pntd.0000728","volume":"4","author":"PT Cantey","year":"2010","unstructured":"Cantey PT, Rout J, Rao G, Williamson J, Fox LAM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis. 2010;4:e728.","journal-title":"PLoS Negl Trop Dis."},{"key":"2999_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2883-6-7","volume":"6","author":"B Nandha","year":"2007","unstructured":"Nandha B, Sadanandane C, Jambulingam P, Das PK. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J. 2007;6:7.","journal-title":"Filaria J."},{"key":"2999_CR36","doi-asserted-by":"crossref","unstructured":"Lemoine JF, Desormeaux AM, Monestime F, Fayette CR, Desir L, Direny AN, et al. Controlling neglected tropical diseases (NTDs) in Haiti: implementation strategies and evidence of their success. PLoS Negl Trop Dis. 2016;10:e0004954.","DOI":"10.1371\/journal.pntd.0004954"},{"key":"2999_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2049-9957-3-31","volume":"3","author":"MA Hussain","year":"2014","unstructured":"Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty. 2014;3:31.","journal-title":"Infect Dis Poverty."},{"key":"2999_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-3156.1996.d01-84.x","volume":"1","author":"KD Ramaiah","year":"1996","unstructured":"Ramaiah KD, Kumar KNV, Ramu K, Vijay Kumar KN. Knowledge and beliefs about transmission, prevention and control of lymphatic filariasis in rural areas of South India. Trop Med Int Heal. 1996;1:433\u20138.","journal-title":"Trop Med Int Heal."},{"key":"2999_CR39","volume-title":"Monitoring and epidemiological assessment of mass drug administration in the Global Programme to Eliminate Lymphatic Filariasis: a manual for national elimination programmes","author":"WHO","year":"2011","unstructured":"WHO. Monitoring and epidemiological assessment of mass drug administration in the Global Programme to Eliminate Lymphatic Filariasis: a manual for national elimination programmes. Geneva: World Health Organization; 2011."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2999-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2999-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2999-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T19:10:24Z","timestamp":1563563424000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2999-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2999"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2999-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before the start of the study, meetings were held in the three study villages to inform the inhabitants on the purpose of the study and to obtain their cooperation. Prior to the interviews, oral informed consent was sought and obtained from all adults, and from parents or guardians of individuals less than 18 years-old. Ethical approval for the study was provided by the Medical Research Coordinating Committee of the National Institute for Medical Research, Tanzania for a large study monitoring LF control in Tanga Region, Tanzania (NIMR\/HQ\/R.8a\/Vol.IX\/1044). This article is published with permission from the director of the Tanzanian National Institute for Medical Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"429"}}